ALEAF (Aleafia Health) EBITDA Margin %: -94.19% (As of Mar. 2023)

What is Aleafia Health EBITDA Margin %?

Aleafia Health ALEAF -99.00% 12 EBITDA Margin % is -94.19% as of Mar. 2023. GuruFocus rates ALEAF with a GF Score™ of 12/100.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Aleafia Health's EBITDA for the three months ended in Mar. 2023 was $-6.47 Mil. Aleafia Health's Revenue for the three months ended in Mar. 2023 was $6.87 Mil. Therefore, Aleafia Health's EBITDA margin for the quarter that ended in Mar. 2023 was -94.19%.

Aleafia Health (GREY:ALEAF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Aleafia Health EBITDA Margin % Related Terms

Aleafia Health EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Aleafia Health's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aleafia Health EBITDA Margin % Chart

Aleafia Health Annual Data

Trend

Jan12

Jan13

Jan14

Jan15

Jan16

Oct17

Dec18

Dec19

Dec20

Mar23

EBITDA Margin %

Get a 7-Day Free Trial

-152.27

-537.05

-110.52

-651.26

-43.61

Aleafia Health Quarterly Data
	Oct17	Jan18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Jun22	Sep22	Dec22	Mar23
EBITDA Margin %	Get a 7-Day Free Trial															-826.09	3.26	105.36	-198.35	-94.19

ALEAF vs ZTS, CTLT, VTRS: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Aleafia Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aleafia Health EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aleafia Health's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Aleafia Health's EBITDA Margin % falls into.

Save Embed

12GF Score

Aleafia Health Inc ALEAF

EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Aleafia Health EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Aleafia Health's EBITDA Margin % for the fiscal year that ended in Mar. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	-13.656	/	31.314
	=	-43.61 %

Aleafia Health's EBITDA Margin % for the quarter that ended in Mar. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Mar. 2023 )	/	Revenue (Q: Mar. 2023 )
	=	-6.466	/	6.865
	=	-94.19 %

Frequently Asked Questions Learn more about EBITDA Margin % →

What does a EBITDA Margin % of -94.19% mean?

Aleafia Health (ALEAF) has a EBITDA Margin % of -94.19% as of Mar. 2023. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Aleafia Health and its competitors.

Is Aleafia Health's EBITDA Margin % too high?

Aleafia Health's current EBITDA Margin % is -94.19%. Overall, Aleafia Health has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.

How does Aleafia Health's EBITDA Margin % compare to ZTS and CTLT?

Aleafia Health's EBITDA Margin % of -94.19% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBITDA Margin % for a Drug Manufacturers company?

The median EBITDA Margin % among Drug Manufacturers companies is 12.39, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBITDA Margin % mean?

A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Aleafia Health and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aleafia Health's current EBITDA Margin % is -94.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Aleafia Health stock overvalued right now?

Aleafia Health (ALEAF) has a current EBITDA Margin % of -94.19%. The current EBITDA Margin % is -94.19%. Aleafia Health's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBITDA Margin % calculated?

EBITDA Margin % is calculated from a company's financial statements. For Aleafia Health (ALEAF), the current EBITDA Margin % is -94.19% as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aleafia Health Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies TSXV:NDVA XCNQ:LOWL TSX:NEPT TSX:ASP XCNQ:VEXT TSXV:DB XCNQ:TRIP XCNQ:MVMD TSX:WLLW TSXV:KHRN XTER:MRK ZTS TSE:4502 NSE:SUNPHARMA CTLT TSE:4507 SHSE:600196 SZSE:000538 VTRS NSE:DIVISLAB

Address 85 Basaltic Road, Concord, ON, CAN, L4K 1G4

Website https://www.aleafiahealth.com

Aleafia Health Inc is a vertically integrated cannabis health and wellness company which owns three cannabis product and cultivation facilities where it produces a diverse portfolio of commercially high-margin derivative products including oils, capsules and sprays.

12GF Score

Get the complete analysis for ALEAF

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00

Price

View ALEAF Analysis

See EBITDA Margin % data for all stocks →